CatalystFDA/Bio

AbbVie submits etentamig BLA for multiple myeloma

AbbVie's BLA submission for etentamig in multiple myeloma signals regulatory progress.

What changed

AbbVie's BLA submission for etentamig in multiple myeloma signals regulatory progress.

Why it matters

AbbVie's BLA submission for etentamig in multiple myeloma signals regulatory progress. — impact context not separately stored; see What changed.

Sources